Executive Summary The Pseudorheumatoid Dysplasia Market, specifically addressing Progressive Pseudorheumatoid Dysplasia (PPD), is a niche segment of the global skeletal dysplasia industry. This rare autosomal recessive genetic disorder, caused by mutations in the CCN6 (WISP3) gene, often mimics juvenile idiopathic arthritis but lacks inflammatory markers. The market is primarily...